All news

Is Inspire Medical Systems (INSP) Fully Priced As New CPT Codes Lift Sentiment?

Alpha Vantage · Simply Wall Street · · AI-summarised by FinFlash

Inspire Medical Systems (INSP) gained investor attention after new Category I CPT codes for its Inspire V system were approved, set to take effect in January 2028. Despite recent share price momentum, the stock has experienced significant long-term declines. Analysts present a mixed valuation, with the most followed narrative suggesting INSP is 16% overvalued against a fair value of $60.40, while its current P/E ratio of 15x suggests it might be cheaper than peers and its own fair ratio.

Read original source

INSP company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.